Yifeng Pharmacy Chain Co., Ltd. (SHA:603939)
28.81
+0.43 (1.52%)
Apr 22, 2025, 1:45 PM CST
Yifeng Pharmacy Chain Revenue
Yifeng Pharmacy Chain had revenue of 5.46B CNY in the quarter ending September 30, 2024, with 5.31% growth. This brings the company's revenue in the last twelve months to 23.92B, up 6.65% year-over-year. In the year 2023, Yifeng Pharmacy Chain had annual revenue of 22.59B with 13.59% growth.
Revenue (ttm)
23.92B
Revenue Growth
+6.65%
P/S Ratio
1.44
Revenue / Employee
603.23K
Employees
39,652
Market Cap
34.41B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 22.59B | 2.70B | 13.59% |
Dec 31, 2022 | 19.89B | 4.56B | 29.75% |
Dec 31, 2021 | 15.33B | 2.18B | 16.60% |
Dec 31, 2020 | 13.14B | 2.87B | 27.91% |
Dec 31, 2019 | 10.28B | 3.36B | 48.66% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 27.98B |
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
WuXi AppTec | 37.92B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
Aier Eye Hospital Group | 20.62B |
Shanghai United Imaging Healthcare | 10.30B |
Sichuan Biokin Pharmaceutical | 5.82B |
Yunnan Baiyao Group Co.,Ltd | 40.03B |